Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8532-8540

  Schwam, D R ^a   Luciano, R L ^a   Mahajan, S S ^a   Wong, L ^a   Wilson, A C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL IMMORTALIZATION; CELL NUCLEUS INCLUSION BODY; DIMERIZATION; EPISOME; GENE EXPRESSION REGULATION; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; VIRUS LATENCY;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CELL LINE; CELL NUCLEUS; CONSERVED SEQUENCE; DIMERIZATION; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; VIRION;

EID: 0033857732     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8532-8540.2000     Document Type: Article

References (48)

1. Primary structure of the herpesvirus saimiri genome
2. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
3. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
4. Kaposi's sarcoma-associated herpesvirus
5. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: Potential switches in latent gene expression due to coinfection
6. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
7. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells
8. A novel, mitogen-activated nuclear kinase is related to a Drosophila developmental regulator
9. Nuclear targeting sequences - A consensus?
10. Regulation of p53 downstream genes
11. Primary structure of the alcelaphine herpesvirus 1 genome
12. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus
13. p53 Inhibition by the LANA protein of KSHV protects against cell death
14. p53 and Apoptosis
15. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: Repression of transcriptional activation by p53
16. High expression of HHV-8-encoded ORF73 protein in spindle-shaped ceils of Kaposi's sarcoma
17. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus
18. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome
19. Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8
20. Sin meets NuRD and other tails of repression
21. HCF-dependent nuclear import of VP16
22. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations
23. EBNA-1: A protein pivotal to latent infection by epstein-barr virus
24. Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks
25. Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids
26. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription
27. ATP-dependent assembly of double hexamers of SV40 T antigen at the viral origin of DNA replication
28. Nuclear domain 10, the site of DNA virus transcription and replication
29. Human herpesvirus 8 - The first human rhadinovirus
30. The role of HHV-8 in Kaposi's sarcoma
31. Cooperative assembly of simian virus 40 T-antigen hexamers on functional halves of the replication origin
32. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene
33. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by off73 and is a component of the latency-associated nuclear antigen
34. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
35. Expression and potential role of Fsrg1, a murine bromodomain-containing homologue of the Drosophila gene female sterile homeotic
36. PHD: Predicting 1D protein structure by profile-based neural networks
37. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
38. Sequence and genomic analysis of a rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
39. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins
40. Nuclear dots: Actors on many stages
41. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line
42. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies
43. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins
44. Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation
45. Complete sequence and genomic analysis of murine gammaherpesvirus 68
46. HCF-1 amino- and carboxy-terminal subunit association through two separate sets of interaction modules: Involvement of fibronectin type 3 repeats
47. VP16 targets an amino-terminal domain of HCF involved in cell cycle progression
48. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lyric (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells